Acute poisoning through new designer drugs T40.7 T43.9
Conditions
Interventions
Group 1: Two Parts:
Part 1:
Retrospective inquiry in the poison control center Freiburg database, regarding cases of human exposure to new designer drugs (cathinone derivatives and other drugs not li
Sponsors
Vergiftungs-Informations-Zentrale, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Exposure to new synthetic Designer Drugs and other (unknown) drugs especially cathinone derivatives and Research chemicals that were not listed in the PCC Databank till 2007, as well as sythetic cannabinoids - Consultation of a medical/emergency Unit - Agreement to participation in Survey
Exclusion criteria
Exclusion criteria: - Non-professional inquiry - Disagreement to participation in Survey
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective: To find out which new drugs lead to consultation of poison control centers and emergency units because of undesirable effects. To correlate symptoms and outcome to the substances found in the toxicological analysis. Toxicological assessment of the drug. To identify the circumstances of consumption that possibly enhance toxicity. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objective: -To discover interaction with other drugs and medication. - To improve the quality of consultation during emergency | — |
Countries
Germany
Contacts
Public ContactUwe Stedtler
Vergiftungs-Informations-Zentrale
Outcome results
None listed